![Corey Fishman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Corey Fishman
Directeur Général chez
Iterum Pharmaceuticals LLC
Fortune : 4 112 $ au 31/03/2026
Profil
Corey N.
Fishman was the founder of Iterum Therapeutics Plc, founded in 2015, where the titles held included President, Chief Executive Officer & Director.
Current jobs include Chief Executive Officer at Iterum Pharmaceuticals LLC, Chief Executive Officer at Iterum Therapeutics US Ltd., Director at Iterum Therapeutics International Ltd., and Director at Iterum Therapeutics US Holding Ltd. Former jobs include Independent Director at BioSpecifics Technologies Corp.
in 2020, Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020, Chief Financial Officer at MedPointe, Inc. from 2002 to 2008, Chief Financial Officer at MedPointe Healthcare, Inc. from 2006 to 2008, Principal at Lyphomed, Inc., Chief Financial Officer at GANIC Pharmaceuticals, Inc. from 2008 to 2010, Chief Financial Officer at Meda Pharmaceuticals, Inc., and Treasurer, Chief Operating & Financial Officer at Durata Therapeutics, Inc. from 2014 to 2015.
Education includes graduate studies at Purdue University and undergraduate studies at the University of Illinois At Urbana–Champaign.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ITERUM THERAPEUTICS PLC 0,26 % | 30/11/2025 | 137 062 ( 0,26 % ) | 4 112 $ | 31/03/2026 |
Postes actifs de Corey Fishman
| Sociétés | Poste | Début |
|---|---|---|
Iterum Pharmaceuticals LLC
 Iterum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Directeur/Membre du Conseil | - |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
Iterum Therapeutics US Ltd.
 Iterum Therapeutics US Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Anciens postes connus de Corey Fishman
| Sociétés | Poste | Fin |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Fondateur | 27/03/2026 |
| BIOSPECIFICS TECHNOLOGIES CORP. | Directeur/Membre du Conseil | 02/12/2020 |
| MOMENTA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 23/06/2020 |
| DURATA THERAPEUTICS INC | Directeur Financier/CFO | 01/02/2015 |
GANIC Pharmaceuticals, Inc.
 GANIC Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops and markets pharmaceutical products | Directeur Financier/CFO | - |
Formation de Corey Fishman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
43
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets, and sells therapeutics | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedPointe Healthcare, Inc.
 MedPointe Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
Lyphomed, Inc.
 Lyphomed, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets injectable drugs | Health Technology |
GANIC Pharmaceuticals, Inc.
GANIC Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops and markets pharmaceutical products | Retail Trade |
Meda Pharmaceuticals, Inc.
 Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs and pharmaceuticals | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Iterum Pharmaceuticals LLC
Iterum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iterum Therapeutics US Ltd.
Iterum Therapeutics US Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Health Technology |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Choisissez Zonebourse 
